GSDMD-dependent IL-1 signaling in intestinal inflammation

肠道炎症中 GSDMD 依赖性 IL-1 信号传导

基本信息

  • 批准号:
    10024455
  • 负责人:
  • 金额:
    $ 54.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-24 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

Abstract: About 1.3 million people suffer from IBD (chronic inflammation of the intestine) in the United States. The etiology of IBD remains elusive and preventive measures or a cure are not available. Inflammasomes and derived cytokines IL-1β are being intensely investigated as the signaling hub that is dys-regulated in inflammatory bowel disease (IBD). IL-1β is synthesized as inactive pro-forms with no secretory signal sequence. Recent studies have found that a lipid binding protein, Gasdermin D (GSDMD), is required for release of IL-1β in response to caspase-1/11 inflammasome activation. This breakthrough led to a rapid growth of literature that focuses on the pore forming and associated pyroptotic activity of GSDMD in myeloid cells. Interestingly, we discovered a novel nonpyrototic role of GSDMD in guiding the release of IL-1β containing vesicles from intestinal epithelia cells and T cells in response to Caspase 8 (Casp8) but not casp1 activation. Through unbiased proteomic analysis, we identified a set of novel GSDMD-interacting proteins in intestinal epithelial cells (IECs), including NEDD4 (an E3 ligase) and the Hsp90 co-chaperone CDC37. Ablation of GSDMD or NEDD4 abolished LPS and ATP-induced IL-1β production from IECs. Strikingly, LPS+ATP stimulation led to the polyubiquitination of pro-IL-1β, which was secreted and processed into mature IL-1β along with a complex containing full-length GSDMD, Hsp90/CDC37, NEDD4, Atg7, Casp8 but not Casp1. In vitro ubiquitination assay demonstrated that NEDD4, known to interact with LC3 and promote cargo loading into secretory vesicles, catalyzed the polyubiquitination of pro-IL-1β. Indeed, while GSDMD was associated with LC3+ vesicles; GSDMD-dependent release of extracellular vesicles (< 200 nm) were detected by electron microscopy, which contains the GSDMD/NEDD4/IL-1β complex. Moreover, inactivating mutation in the Asp276 of GSDMD, which abolishes its pore-forming and pyroptotic activity, did not impact the GSDMD-guided IL-1β secretion from IECs. In TH17 cells, a T helper cell subset highly relevant to intestinal inflammation, this GSDMD-guided secretion of polyubiquitinated pro-IL-1β complex (GSDMD, Hsp90, Casp8 and NEDD4) was also readily detected in response to ATP stimulation and TCR activation. Collectively, the data revealed a novel nonpyroptotic role for GSDMD in IL-1β release from non-myeloid cells. The pathogenic role of the GSDMD-guided IL-1β release was investigated in two mouse models of intestinal inflammation. Firstly, while polyubiquitinated pro-IL-1β, mIL-1β and the GSDMD/NEDD4-secretary complex were induced in a GSDMD-dependent manner in the intestinal explants in response to dextran sodium sulfate (DSS)-induce colitis, GSDMD-deficiency attenuated the intestinal inflammation. Secondly, GSDMD or IL-1β deficiency in naïve T cells reduced their ability to elicit intestinal inflammation. Based on these findings, we hypothesize that the GSDMD mediates distinct pathways (guided secretion and pyroptosis) for IL-1β release in non-myeloid and myeloid cells, which jointly contribute to the pathogenesis of intestinal inflammation in a coordinated manner. We will test this hypothesis through the following aims: (1) Investigate the molecular mechanism for GSDMD-guided secretory pathway for IL-1β release; (2) Investigate the cell-type and pathway-specific role of GSDMD-IL-1β axis in intestinal inflammation, including GSDMD-mediated pyroptotic versus GSDMD-guided IL-1β secretion on the intestinal inflammation.
摘要: 在美国,大约有130万人患有IBD(慢性肠道炎症)。病因 IBD仍然难以捉摸,预防措施或治愈方法不可用。炎性小体及其衍生物 细胞因子IL-1β作为炎症性肠病中调节异常的信号中枢, 疾病(IBD)。IL-1β作为无分泌信号序列的无活性前体合成。最近的研究 已经发现一种脂质结合蛋白Gasdermin D(GSDMD)是响应于 caspase-1/11炎性体激活。这一突破导致了文学的快速增长,重点是 骨髓细胞中GSDMD的孔形成和相关的致热活性。有趣的是,我们发现了一本小说 GSDMD在引导含IL-1β的囊泡从肠上皮细胞释放中的非致热作用, T细胞响应于Caspase 8(Casp 8)而非Casp 1活化。通过无偏的蛋白质组学分析,我们 在肠上皮细胞(IEC)中鉴定了一组新的GSDMD相互作用蛋白,包括NEDD 4(E3 连接酶)和Hsp 90共分子伴侣CDC 37。GSDMD或NEDD 4的消融消除了LPS和ATP诱导的细胞凋亡。 来自IEC的IL-1β产生。引人注目的是,LPS+ATP刺激导致pro-IL-1β的多泛素化, 分泌并加工成成熟的IL-1β沿着含有全长GSDMD、Hsp 90/CDC 37的复合物, NEDD 4,Atg 7,Casp 8,但不是Casp 1。体外泛素化分析表明,已知与NEDD 4相互作用的NEDD 4, 与LC 3和促进货物装载到分泌囊泡中,催化pro-IL-1β的多聚泛素化。的确, 而GSDMD与LC 3+囊泡相关; GSDMD依赖的细胞外囊泡(< 200 透射电镜下观察到GSDMD/NEDD 4/IL-1β复合物的存在。此外,委员会认为, GSDMD的Asp 276中的失活突变消除了其孔形成和致热原活性, 影响GSDMD引导的IL-1β从IEC分泌。在TH 17细胞中,一个与T细胞亚群高度相关的T辅助细胞亚群, 肠道炎症,这种GSDMD引导的多聚泛素化前IL-1β复合物(GSDMD,Hsp 90, Casp 8和NEDD 4)也响应于ATP刺激和TCR活化而容易检测到。总的来说, 这些数据揭示了GSDMD在IL-1β从非骨髓细胞释放中的新的非致热作用。致病 在两种小鼠肠道炎症模型中研究了GSDMD引导的IL-1β释放的作用。第一、 而多泛素化的pro-IL-1β、mIL-1β和GSDMD/NEDD 4分泌复合物则被诱导为一种新的细胞因子, 葡聚糖硫酸钠(DSS)诱导的结肠炎在肠外植体中的GSDMD依赖性方式, GSDMD缺乏减轻了肠道炎症。第二,幼稚T细胞中的GSDMD或IL-1β缺乏 降低了它们引发肠道炎症的能力。基于这些发现,我们假设GSDMD 介导非髓细胞和髓细胞中IL-1β释放的不同途径(引导分泌和焦亡), 它们以协调的方式共同促进肠道炎症的发病。我们将测试这个 本研究通过以下几个方面对GSDMD的分子机制进行了初步探讨:(1)探讨GSDMD介导的细胞分泌的分子机制 (2)研究GSDMD-IL-1β轴在IL-1β释放中的细胞类型和途径特异性作用。 肠道炎症,包括GSDMD介导的焦萎与GSDMD引导的IL-1β分泌, 肠道炎症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaoxia Li其他文献

Xiaoxia Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaoxia Li', 18)}}的其他基金

Core B: Animal Model and Immunotyping Core
核心 B:动物模型和免疫分型核心
  • 批准号:
    10493942
  • 财政年份:
    2022
  • 资助金额:
    $ 54.17万
  • 项目类别:
IL-17-driven mechanisms for tumor progression and resistance to therapies
IL-17 驱动的肿瘤进展和治疗耐药机制
  • 批准号:
    10493940
  • 财政年份:
    2022
  • 资助金额:
    $ 54.17万
  • 项目类别:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
TRAF4 E3 连接酶在 IL-25 介导的过敏性哮喘中的作用
  • 批准号:
    10112955
  • 财政年份:
    2020
  • 资助金额:
    $ 54.17万
  • 项目类别:
The role of TRAF4 E3 ligase in IL-25-mediated allergic asthma
TRAF4 E3 连接酶在 IL-25 介导的过敏性哮喘中的作用
  • 批准号:
    9885028
  • 财政年份:
    2020
  • 资助金额:
    $ 54.17万
  • 项目类别:
IRAKM and Mincle in ALD
IRAKM 和 Mincle 在 ALD 中
  • 批准号:
    9067893
  • 财政年份:
    2015
  • 资助金额:
    $ 54.17万
  • 项目类别:
IRAKM and Mincle in ALD
IRAKM 和 Mincle 在 ALD 中
  • 批准号:
    8912063
  • 财政年份:
    2015
  • 资助金额:
    $ 54.17万
  • 项目类别:
Myeloid cells, aging and the metabolic syndrome
骨髓细胞、衰老和代谢综合征
  • 批准号:
    8702069
  • 财政年份:
    2013
  • 资助金额:
    $ 54.17万
  • 项目类别:
Myeloid cells, aging and the metabolic syndrome
骨髓细胞、衰老和代谢综合征
  • 批准号:
    8611557
  • 财政年份:
    2013
  • 资助金额:
    $ 54.17万
  • 项目类别:
Molecular mechanisms of IL-1R-TLR mediated signaling
IL-1R-TLR介导信号传导的分子机制
  • 批准号:
    8242732
  • 财政年份:
    2011
  • 资助金额:
    $ 54.17万
  • 项目类别:
Molecular and Cellular Mechanisms of IL-17 Signaling
IL-17 信号传导的分子和细胞机制
  • 批准号:
    8453438
  • 财政年份:
    2011
  • 资助金额:
    $ 54.17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了